Our #newest issue is out now and available to read now! This issue is full of the latest #SUD research out there. Make sure to read our #special editorial around #OUD during this #COVID19 pandemic.
Volume 41, Issue 2
Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment
Traci C. Green PhD, MSc, Jeffrey Bratberg PharmD, FAPhA & Deborah S. Finnell DNS, RN, CARN-AP, FAAN
An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated
Emma R. Brezel MBE, Tia Powell MD & Aaron D. Fox MD, MS
Pharmacokinetic and pharmacodynamic of the cognitive enhancer modafinil: Relevant clinical and forensic aspects
Ana Sousa MSc & Ricardo Jorge Dinis-Oliveira PhD
Implementing group visits for opioid use disorder: A case series
Randi Sokol MD, MPH, MMedEd, Mark Albanese MD, Chiara Albanese BA, Gerard Coste MD, Ellie Grossman MD, MPH, Diana Morrill BA, David Roll MD, Amy Sobieszczyk LICSW & Zev Schuman-Olivier MD
Consideration of opioid agonist treatment in a pregnant adolescent: A case report and literature review
Meredith Spada MD, Julie Kmiec DO, Jody B. Glance MD & Priya Gopalan MD
Text messaging promoting physician-led brief intervention tobacco cessation: A before-and-after study among physicians in three tertiary hospitals in Nigeria
Oluwakemi Odukoya MPH, Babalola Faseru MPH, Nkolika Uguru MPH, Mustapha Jamda MPH, Olanrewaju Onigbogi MPH, Oluwafunmilola James MSc, Scott Leischow PhD & Olalekan Ayo-Yusuf PhD
Severity of DSM-5 cannabis use disorders in a nationally representative sample of sexual minorities
Carol J. Boyd PhD, MSN, FAAN, Philip T. Veliz PhD & Sean Esteban McCabe PhD
Health-related material needs and substance use among emergency department patients
Evan Gerber BS, Lillian Gelberg MD, MSPH, John Rotrosen MD, Donna CastelblancoMBE, Tod Mijanovich PhD & Kelly M. Doran MD, MHS
Behavioral economic demand for alcohol among young adults who engage in simultaneous alcohol and marijuana use
Jason J. Ramirez PhD, Jennifer M. Cadigan PhD & Christine M. Lee PhD
Beneficial opioid management strategies: A review of the evidence for the use of opioid treatment agreements
Tuesday M. McAuliffe Staehler PharmD/MPH Candidate & Laura C. Palombi PharmD, MPH, MAT
The relationship between patient-centered care and outcomes in specialist drug and alcohol treatment: A systematic literature review
Esther L. Davis PhD (Clin Psyc), Peter J. Kelly PhD (Clin Psyc), Frank P. Deane PhD, Amanda L. Baker PhD, Mark Buckingham PostGradDip (Hlth M), Tayla Degan BPsyc (Hons) & Sarah Adams MCP
Racial inequities in U.S. naloxone prescriptions
Erin Fanning Madden PHD MPH & Fares Qeadan PHD MS
Concerns that an opioid antidote could “make things worse”: Profiles of risk compensation beliefs using the Naloxone-Related Risk Compensation Beliefs (NaRRC-B) scale
Rachel P. Winograd PhD, Kim B. Werner PhD, Lauren Green BS, Sarah Phillips MA, Jenny Armbruster MEd & Robert Paul PhD
Changes in voluntary admission and restraint use after a comprehensive tobacco-free policy in inpatient psychiatric health facilities
Annaka Scheeres BS, Regina Xhezo MS, PMP, Rose Julius DO, MPH, Ryan CoffmanMPH, CHES, CTTS-M, Jarma Frisby MS, Luise Weber MPH, BSN, Jessica Streeter MA, Frank Leone MD, MS, Cheryl Bettigole MD, MPH & Hannah Lawman PhD
Adoption of the 275-patient buprenorphine treatment waiver for treating opioid use disorder: A state-level longitudinal analysis
Hannah K. Knudsen PhD, Lewei (Allison) Lin MD & Michelle R. Lofwall MD